Identification and characterization of host proteins involved in the alphavirus exit pathway
甲病毒退出途径中宿主蛋白的鉴定和表征
基本信息
- 批准号:10352876
- 负责人:
- 金额:$ 25.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlphavirusAntiviral AgentsAntiviral TherapyArthritogenicBioinformaticsBiologicalBiological AssayBiotinBiotinylationCapsidCapsid ProteinsCell membraneCellsChemicalsChikungunya virusCollaborationsCrosslinkerCytoplasmDataDiseaseEnzymesEvaluationFlow CytometryGenomeGrantHumanInfectionIntegral Membrane ProteinIntegration Host FactorsKnock-inKnock-outLabelLigaseLipid BilayersLocationMass Spectrum AnalysisMayaro virusMediatingMedicalMembraneMembrane FusionMethodsNatureNucleocapsidPathway interactionsPeptidesPermeabilityPlasma CellsPrimary InfectionProcessProductionProtein AnalysisProtein BiosynthesisProteinsProteomeProteomicsPublishingRNARNA VirusesReporterRetrievalRiversRoleRoss river virusSamplingSemliki forest virusSindbis VirusSiteSmall Interfering RNAStatistical Data InterpretationStreptavidinStructural ProteinStructureSystemTestingTrypsinVaccinesVenezuelan Equine Encephalitis VirusVesicular stomatitis Indiana virusViralVirionVirusVirus-like particlebasebiodefensechikungunyacrosslinkemerging human pathogenhuman pathogenmagnetic beadsmutantnovelnovel strategiesoverexpressionparticleprotein crosslinksecondary infectionuptakeviral resistancevirus envelope
项目摘要
Alphaviruses include important and emerging human pathogens such as encephalitic viruses and the
arthritogenic Chikungunya, Ross River, and Mayaro viruses. There are currently no licensed antiviral therapies
or vaccines, and new approaches and information are needed to develop antiviral strategies.
Alphaviruses are small enveloped RNA viruses with highly ordered structures. The nucleocapsid core is
composed of the plus-sense RNA genome enclosed in a capsid protein shell, and is surrounded by the virus
envelope, a membrane containing an organized lattice of the E2 and E1 transmembrane proteins. There is
increasing understanding of alphavirus structure, entry, and replication, and the functions of host proteins in
these processes. In contrast, much less is known about the roles of host proteins in the late steps of the
alphavirus exit pathway, including nucleocapsid assembly/transport and virus budding at the plasma
membrane. This grant aims to use proteomics to identify host proteins that interact with the virus capsid
protein, and determine their roles in virus exit. Such an approach has been difficult because capsid protein is
highly basic in nature and interacts non-specifically with host proteins during retrieval. Tagging the capsid
protein with relatively large tags such as fluorescent proteins leads to major distortions in the organized capsid
lattice and the viral particle. Instead, we have developed an approach based on insertion of a 13 residue biotin
acceptor peptide into a permissive site on capsid. Infection of cells expressing the BirA biotinylation enzyme
leads to efficient biotin labeling of capsid and nucleocapsid in cells and virus particles. Our preliminary data
have established efficient and specific retrieval of biotinylated capsid using Streptavidin magnetic beads. We
will use this system to identify capsid-associated cellular proteins in infected cells. The specific aims are:
1. Use a novel biotin-based capsid pull-down strategy to identify host proteins involved in
alphavirus exit. We will use our optimized methods to perform chemical crosslinking, specific biotin-based
retrieval, and elution of capsid-associated cellular proteins. Proteins will be identified by state of the art mass
spectrometry methods and prioritized for further study based on statistical and bioinformatics analyses of
samples and controls, and on protein cellular locations, pathways, and functions.
2. Define the role of host proteins in alphavirus exit. We will test a prioritized set of candidate host
proteins for roles in the alphavirus exit pathway. Host proteins will be depleted by siRNA targeting and effects
on alphavirus primary infection and virus production determined. Proteins showing the most specific effects on
alphavirus exit will be further characterized in knock-out and overexpressing cells using our established battery
of assays for defined steps in virus exit.
The results of these studies will provide fundamental information on host proteins that affect alphavirus
assembly and budding, and potential new targets for antiviral strategies.
甲病毒包括重要的和新出现的人类病原体,例如脑炎病毒和
致关节炎的基孔肯雅病毒、罗斯河病毒和马亚罗病毒。目前没有获得许可的抗病毒疗法
或疫苗,并且需要新的方法和信息来制定抗病毒策略。
甲病毒是具有高度有序结构的小包膜RNA病毒。核衣壳核心是
由包裹在衣壳蛋白壳中的正链RNA基因组组成,并被病毒包围
包膜,一种含有 E2 和 E1 跨膜蛋白组织晶格的膜。有
增加对甲病毒结构、进入和复制以及宿主蛋白功能的了解
这些过程。相比之下,人们对宿主蛋白在最后步骤中的作用知之甚少。
甲病毒退出途径,包括核衣壳组装/运输和病毒在血浆中出芽
膜。该资助旨在利用蛋白质组学来识别与病毒衣壳相互作用的宿主蛋白
蛋白质,并确定它们在病毒退出中的作用。这种方法很困难,因为衣壳蛋白是
本质上是高度碱性的,并且在修复过程中与宿主蛋白发生非特异性相互作用。标记衣壳
具有相对较大标签的蛋白质(例如荧光蛋白)会导致有组织的衣壳发生严重扭曲
晶格和病毒颗粒。相反,我们开发了一种基于插入 13 个残基生物素的方法
受体肽进入衣壳上的允许位点。表达 BirA 生物素化酶的细胞的感染
导致细胞和病毒颗粒中衣壳和核衣壳的有效生物素标记。我们的初步数据
已经建立了使用链霉亲和素磁珠对生物素化衣壳进行高效且特异性的检索。我们
将使用该系统来识别受感染细胞中的衣壳相关细胞蛋白。具体目标是:
1. 使用一种新型的基于生物素的衣壳下拉策略来识别参与的宿主蛋白
甲病毒退出。我们将使用我们优化的方法进行化学交联,特定的生物素基
衣壳相关细胞蛋白的检索和洗脱。蛋白质将通过最先进的质量进行鉴定
光谱测定方法,并根据统计和生物信息学分析优先进行进一步研究
样品和对照,以及蛋白质细胞位置、途径和功能。
2. 定义宿主蛋白在甲病毒退出中的作用。我们将测试一组优先的候选主机
在甲病毒退出途径中发挥作用的蛋白质。宿主蛋白将被 siRNA 靶向和效应耗尽
对甲病毒的初次感染和病毒产生进行了测定。显示出最具体效果的蛋白质
甲病毒退出将使用我们建立的电池在敲除和过度表达细胞中进一步表征
病毒退出过程中确定步骤的检测。
这些研究的结果将提供影响甲病毒的宿主蛋白的基本信息
组装和萌芽,以及抗病毒策略的潜在新目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET KIELIAN其他文献
MARGARET KIELIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET KIELIAN', 18)}}的其他基金
Project 6 - Development of Antivirals against Alphaviruses
项目 6 - 开发抗甲病毒的抗病毒药物
- 批准号:
10513947 - 财政年份:2022
- 资助金额:
$ 25.2万 - 项目类别:
Identification and characterization of host proteins involved in the alphavirus exit pathway
甲病毒退出途径中宿主蛋白的鉴定和表征
- 批准号:
10495264 - 财政年份:2021
- 资助金额:
$ 25.2万 - 项目类别:
Mechanism and inhibition of dengue and chikungunya virus fusion protiens
登革热和基孔肯雅病毒融合蛋白的作用机制及抑制作用
- 批准号:
8230243 - 财政年份:2011
- 资助金额:
$ 25.2万 - 项目类别:
Mechanism and inhibition of dengue and chikungunya virus fusion protiens
登革热和基孔肯雅病毒融合蛋白的作用机制及抑制作用
- 批准号:
7670803 - 财政年份:2009
- 资助金额:
$ 25.2万 - 项目类别:
Molecular Analysis of Alphavirus Membrane Fusion Protein
甲病毒膜融合蛋白的分子分析
- 批准号:
7919163 - 财政年份:2009
- 资助金额:
$ 25.2万 - 项目类别:
Molecular Mechanisms of Alphavirus Entry and Exit
甲病毒进入和退出的分子机制
- 批准号:
7922849 - 财政年份:2009
- 资助金额:
$ 25.2万 - 项目类别:
Inhibition of the Membrane Fusion Proteins of Flaviviruses and Alphaviruses
黄病毒和甲病毒膜融合蛋白的抑制
- 批准号:
7255226 - 财政年份:2007
- 资助金额:
$ 25.2万 - 项目类别:
Inhibition of the Membrane Fusion Proteins of Flaviviruses and Alphaviruses
黄病毒和甲病毒膜融合蛋白的抑制
- 批准号:
7414889 - 财政年份:2007
- 资助金额:
$ 25.2万 - 项目类别:
MOLECULAR MECHANISMS OF ALPHAVIRUS ENTRY AND EXIT
甲病毒进入和退出的分子机制
- 批准号:
6351246 - 财政年份:1999
- 资助金额:
$ 25.2万 - 项目类别:
Molecular Mechanisms of Alphavirus Entry and Exit
甲病毒进入和退出的分子机制
- 批准号:
7010380 - 财政年份:1999
- 资助金额:
$ 25.2万 - 项目类别:
相似国自然基金
新发猪肠道甲型冠状病毒的细胞入侵及跨种传播的分子机制研究
- 批准号:31872488
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Intracellular functions and mechanisms of alphavirus ion channel 6K
甲病毒离子通道6K的细胞内功能和机制
- 批准号:
10727819 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Structural Biology and Computational Modeling Core
结构生物学和计算建模核心
- 批准号:
10513917 - 财政年份:2022
- 资助金额:
$ 25.2万 - 项目类别:
Cell intrinsic antiviral mechanisms targeting human enteroviruses
针对人类肠道病毒的细胞内在抗病毒机制
- 批准号:
10449724 - 财政年份:2022
- 资助金额:
$ 25.2万 - 项目类别:
Cell intrinsic antiviral mechanisms targeting human enteroviruses
针对人类肠道病毒的细胞内在抗病毒机制
- 批准号:
10595616 - 财政年份:2022
- 资助金额:
$ 25.2万 - 项目类别: